GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » Cyclically Adjusted PS Ratio

COSM (Cosmos Health) Cyclically Adjusted PS Ratio : 0.01 (As of May. 31, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Cosmos Health Cyclically Adjusted PS Ratio?

As of today (2025-05-31), Cosmos Health's current share price is $0.44535. Cosmos Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $57.21. Cosmos Health's Cyclically Adjusted PS Ratio for today is 0.01.

The historical rank and industry rank for Cosmos Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

COSM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.24   Max: 3.57
Current: 0.01

During the past years, Cosmos Health's highest Cyclically Adjusted PS Ratio was 3.57. The lowest was 0.01. And the median was 0.24.

COSM's Cyclically Adjusted PS Ratio is ranked better than
98.68% of 76 companies
in the Medical Distribution industry
Industry Median: 0.4 vs COSM: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cosmos Health's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.527. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $57.21 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cosmos Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cosmos Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmos Health Cyclically Adjusted PS Ratio Chart

Cosmos Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.48 1.44 0.07 0.02 0.01

Cosmos Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.02 0.01 0.01

Competitive Comparison of Cosmos Health's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Cosmos Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmos Health's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cosmos Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cosmos Health's Cyclically Adjusted PS Ratio falls into.


;
;

Cosmos Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cosmos Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.44535/57.21
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmos Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Cosmos Health's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.527/120.1327*120.1327
=0.527

Current CPI (Mar. 2025) = 120.1327.

Cosmos Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.000 100.838 0.000
201509 0.000 100.856 0.000
201512 1.062 100.087 1.275
201603 2.258 99.041 2.739
201606 1.901 100.121 2.281
201609 2.813 99.878 3.383
201612 6.459 100.110 7.751
201703 8.118 100.770 9.678
201706 11.963 101.138 14.210
201709 18.610 100.882 22.161
201712 19.957 100.762 23.793
201803 23.324 100.534 27.871
201806 16.743 102.121 19.696
201809 15.669 101.982 18.458
201812 14.278 101.330 16.927
201903 18.099 101.482 21.425
201906 16.064 101.837 18.950
201909 18.310 101.906 21.585
201912 22.293 102.120 26.225
202003 22.558 101.479 26.705
202006 24.189 100.239 28.990
202009 27.028 99.886 32.507
202012 30.299 99.751 36.490
202103 19.333 99.817 23.268
202106 23.054 101.270 27.348
202109 19.847 102.095 23.353
202112 23.278 104.853 26.670
202203 18.411 108.651 20.357
202206 16.891 113.517 17.875
202209 11.643 114.371 12.230
202212 1.138 112.428 1.216
202303 1.163 113.620 1.230
202306 1.143 115.515 1.189
202309 1.019 116.234 1.053
202312 1.145 116.364 1.182
202403 0.865 117.285 0.886
202406 0.741 118.129 0.754
202409 0.674 119.650 0.677
202412 0.607 119.360 0.611
202503 0.527 120.133 0.527

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cosmos Health  (NAS:COSM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cosmos Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cosmos Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmos Health Business Description

Traded in Other Exchanges
N/A
Address
5 Agiou Georgiou Street, Thessaloniki, Thessaloniki, GRC, 55438
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Executives
Grigorios Siokas 10 percent owner 5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001
Georgios Terzis officer: Chief Financial Officer 2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121
Suhel Bhutawala director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Nikolaos Bardakis officer: Chief Operating Officer 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Manfred Ziegler director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Anastasios Aslidis director 11 CANTERBURY LANE, WATCHUNG NJ 07069
Pavlos Ignatiades officer: Chief Operating Officer KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236
Peter Goldstein director 151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324
John James Hoidas director 9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453
Dimitrios Goulielmos director, 10 percent owner, officer: CEO 141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604
Panagiotis Tolis director, officer: Secretary PERICLEOUS 50 STREET, ATHENS J3 15232
Panagiotis Drakopoulos director, 10 percent owner, officer: CEO 200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606
Vasileios Mavrogiannis director, 10 percent owner, officer: CFO TERTSETI 23 STREET, KESARIANI J3 16122

Cosmos Health Headlines

From GuruFocus